CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-tyrosine kinase inhibitor via suppressing PI3K/AKT
CDK12 抑制通过抑制 PI3K/AKT 增强 HER2+ 乳腺癌对 HER2-酪氨酸激酶抑制剂的敏感性
期刊:European Journal of Cancer
影响因子:7.6
doi:10.1016/j.ejca.2020.11.045
Hui Li, Jinsong Wang, Zongbi Yi, Chunxiao Li, Haijuan Wang, Jingyao Zhang, Ting Wang, Peng Nan, Feng Lin, Dongkui Xu, Haili Qian, Fei Ma